Contact
searchSearch
HMP Global

Rosacea Topic Center

Featured

rosacea
News
Consensus on a Core Outcome Set for Rosacea in Clinical Trials and Practice
10/31/2024
Riya Gandhi, MA
A standardized set of outcomes could facilitate more effective data comparison across studies, improving research and clinical care for rosacea.
A standardized set of outcomes could facilitate more effective data comparison across studies, improving research and clinical care for rosacea.
A standardized set of outcomes...
10/31/2024
The Dermatologist
News
Lower Quality of Life Reported Among Patients With Acne, Rosacea, and Seborrheic Dermatitis
04/10/2023
Lisa Kuhns, PhD, MD
The quality of life among patients with acne, rosacea, and seborrheic dermatitis is significantly lower when compared with healthy people, and these patients experience more negative feelings about themselves as a result of their skin...
The quality of life among patients with acne, rosacea, and seborrheic dermatitis is significantly lower when compared with healthy people, and these patients experience more negative feelings about themselves as a result of their skin...
The quality of life among...
04/10/2023
The Dermatologist
News
Trait Emotional Intelligence Protective Against Distressing States in Rosacea
04/05/2023
Lisa Kuhns, PhD, MD
Self-esteem and social phobia mediate the relationship between trait emotional intelligence (EI) and general distress, and high levels of trait El may protect against the onset of distressing states in rosacea, according to a study published...
Self-esteem and social phobia mediate the relationship between trait emotional intelligence (EI) and general distress, and high levels of trait El may protect against the onset of distressing states in rosacea, according to a study published...
Self-esteem and social phobia...
04/05/2023
The Dermatologist
News
Rosacea in Patients With Diabetes Increases the Risk of Eye Diseases
12/06/2022
Riya Gandhi, MA
According to a study published in The Asia-Pacific Journal of Ophthalmology, patients with diabetes and rosacea are at an increased risk for diabetic macular edema, dry eye disease, glaucoma, and cataract.
According to a study published in The Asia-Pacific Journal of Ophthalmology, patients with diabetes and rosacea are at an increased risk for diabetic macular edema, dry eye disease, glaucoma, and cataract.
According to a study published...
12/06/2022
The Dermatologist
News
Consensus Recommendations on Holistic Skin Care Routines for Dermatologic Conditions
12/06/2022
Jessica Garlewicz
Consensus recommendations on providing practical guidance on the role of cleansing, moisturizing, and photoprotection (CMP) in holistic care to reach a better patient compliance, satisfaction, and treatment outcome are outlined in a recent...
Consensus recommendations on providing practical guidance on the role of cleansing, moisturizing, and photoprotection (CMP) in holistic care to reach a better patient compliance, satisfaction, and treatment outcome are outlined in a recent...
Consensus recommendations on...
12/06/2022
The Dermatologist
News
Ivermectin Is an Efficient Treatment for Rosacea
10/19/2022
Riya Gandhi, MA
Researchers aimed to investigate ivermectin treatment in rosacea and how novel smartphone technology can support monitoring rosacea-associated signs and symptoms in an open monocentric pilot study.
Researchers aimed to investigate ivermectin treatment in rosacea and how novel smartphone technology can support monitoring rosacea-associated signs and symptoms in an open monocentric pilot study.
Researchers aimed to investigate...
10/19/2022
The Dermatologist
News
Patients With Blepharitis Should Be Examined for Facial Dermatoses
10/19/2022
Jessica Garlewicz
According to a recent study published in Dermatology Practical & Conceptual, facial dermatoses frequently occur in patients with blepharitis. These patients should be examined in dermatology clinics for early detection, which will improve...
According to a recent study published in Dermatology Practical & Conceptual, facial dermatoses frequently occur in patients with blepharitis. These patients should be examined in dermatology clinics for early detection, which will improve...
According to a recent study...
10/19/2022
The Dermatologist
News
Long-Pulsed Alexandrite Plus Low-Fluence Nd:YAG Laser to Treat Rosacea
10/19/2022
Riya Gandhi, MA
According to a study published in Lasers in Surgery and Medicine, long-pulsed alexandrite laser (LPAL) may be an alternative treatment option for rosacea, producing results comparable to pulsed-dye laser (PDL) in reducing the erythema index...
According to a study published in Lasers in Surgery and Medicine, long-pulsed alexandrite laser (LPAL) may be an alternative treatment option for rosacea, producing results comparable to pulsed-dye laser (PDL) in reducing the erythema index...
According to a study published...
10/19/2022
The Dermatologist
NRS Approved Features
Results of a Patient Survey on Rosacea Redness
10/18/2022
Mary Erhard
Persistent erythema is the most common and bothersome sign of rosacea, according to respondents. This highly visible phenotype may lead to serious invisible burdens.
Persistent erythema is the most common and bothersome sign of rosacea, according to respondents. This highly visible phenotype may lead to serious invisible burdens.
Persistent erythema is the most...
10/18/2022
The Dermatologist
News
BDNF Serum Level is a Potential Biomarker for Depression in Patients With Rosacea
07/08/2022
Riya Gandhi, MA
Researchers aimed to demonstrate the potential association between BDNF and depression in patients with rosacea.
Researchers aimed to demonstrate the potential association between BDNF and depression in patients with rosacea.
Researchers aimed to demonstrate...
07/08/2022
The Dermatologist
Cover Story
Tips for Physicians to Increase Adherence to Rosacea Therapy
05/13/2022
Julie C. Harper, MD, FAAD
If your patients are struggling with adhering to the treatment plan, there may be a good reason. When we find out why by actively listening, we can make adjustments and help them achieve and maintain a successful outcome.
If your patients are struggling with adhering to the treatment plan, there may be a good reason. When we find out why by actively listening, we can make adjustments and help them achieve and maintain a successful outcome.
If your patients are struggling...
05/13/2022
The Dermatologist

Partner Approved

NRS Approved Features
Results of a Patient Survey on Rosacea Redness
10/18/2022
Mary Erhard
Persistent erythema is the most common and bothersome sign of rosacea, according to respondents. This highly visible phenotype may lead to serious invisible burdens.
Persistent erythema is the most common and bothersome sign of rosacea, according to respondents. This highly visible phenotype may lead to serious invisible burdens.
Persistent erythema is the most...
10/18/2022
The Dermatologist
NRS Approved Features
Raising Awareness for Rosacea Treatment Adherence
05/13/2022
Amanda Balbi
Rosacea is a chronic disease, and treatment adherence impacts patients’ quality of life. There are numerous treatments available and more in the pipeline. To better understand the treatments and the importance of treatment adherence, Hilary...
Rosacea is a chronic disease, and treatment adherence impacts patients’ quality of life. There are numerous treatments available and more in the pipeline. To better understand the treatments and the importance of treatment adherence, Hilary...
Rosacea is a chronic disease,...
05/13/2022
The Dermatologist
NRS Approved Features
Pop Quiz: Rosacea Research
02/11/2022
Andrew Huff
Rosacea is a common dermatologic condition affecting the face. New research aims to better understand the condition in order to improve diagnosis rates and patient care. Test your knowledge with this quiz series on recent research!
Rosacea is a common dermatologic condition affecting the face. New research aims to better understand the condition in order to improve diagnosis rates and patient care. Test your knowledge with this quiz series on recent research!
Rosacea is a common dermatologic...
02/11/2022
The Dermatologist
NRS Approved Features
Laser and Light Sources for the Treatment of Rosacea
12/08/2021
Arisa Ortiz, MD, FAAD
While there is no one standard treatment approach to rosacea, laser therapy can be an effective option for patients with the disease.
While there is no one standard treatment approach to rosacea, laser therapy can be an effective option for patients with the disease.
While there is no one standard...
12/08/2021
The Dermatologist
Masks Can Matter in the Fight Against Rosacea
NRS Approved Features
Masks Can Matter in the Fight Against Rosacea
05/17/2021
Jessica Garlewicz
Every April is Rosacea Awareness Month. After a year of fighting the pandemic, awareness of rosacea is on the rise, with patients and providers seeing flares in facial erythema with prolonged mask use.
Every April is Rosacea Awareness Month. After a year of fighting the pandemic, awareness of rosacea is on the rise, with patients and providers seeing flares in facial erythema with prolonged mask use.
Every April is Rosacea Awareness...
05/17/2021
The Dermatologist
Diagnosing Rosacea in Patients With Skin of Color
Partner Approved
Diagnosing Rosacea in Patients With Skin of Color
10/16/2020
Melissa Weiss
While anyone can present with rosacea, this condition is often underdiagnosed among patients with darker phototypes. Dr Susan Taylor shares her clinical pearls for identifying rosacea in patients with skin of color.
While anyone can present with rosacea, this condition is often underdiagnosed among patients with darker phototypes. Dr Susan Taylor shares her clinical pearls for identifying rosacea in patients with skin of color.
While anyone can present with...
10/16/2020
The Dermatologist
Best Practices for Treating Rosacea: Q&A With Dr Linda Stein Gold
Partner Approved
Best Practices for Treating Rosacea: Q&A With Dr Linda Stein Gold
02/13/2020
Melissa Weiss
It is no secret that rosacea can cause significant stress on patients and affect quality of life. The Dermatologist spoke with Linda Stein Gold, MD, about the current best practices for treating rosacea, as well as new therapies under...
It is no secret that rosacea can cause significant stress on patients and affect quality of life. The Dermatologist spoke with Linda Stein Gold, MD, about the current best practices for treating rosacea, as well as new therapies under...
It is no secret that rosacea can...
02/13/2020
The Dermatologist
NRS Approved Features
Rosacea in Older People: Less Common or Underdiagnosed?
08/02/2025
Andrew Huff
New research explores whether decreased rosacea prevalence in older adults is a result of aging skin being less prone to the condition or physicians mistaking persistent erythema and telangiectasia as normal signs of aging.
New research explores whether decreased rosacea prevalence in older adults is a result of aging skin being less prone to the condition or physicians mistaking persistent erythema and telangiectasia as normal signs of aging.
New research explores whether...
08/02/2025
The Dermatologist
NRS Approved Features
The Latest in Rosacea News
05/01/2025
Mary Erhard
National Rosacea Society offers a new version of its treatment algorithms for physicians, announces the results of a recently funded study on ivermectin, and celebrates 25 years of awarding research grants.
National Rosacea Society offers a new version of its treatment algorithms for physicians, announces the results of a recently funded study on ivermectin, and celebrates 25 years of awarding research grants.
National Rosacea Society offers...
05/01/2025
The Dermatologist
NRS Approved Features
Hormonal Intrauterine Devices May Increase Rosacea Risk
02/03/2025
Andrew Huff
Although further study is required to determine if there is a cause-and-effect relationship, recent research findings suggest a potential association.
Although further study is required to determine if there is a cause-and-effect relationship, recent research findings suggest a potential association.
Although further study is...
02/03/2025
The Dermatologist
NRS Approved Features
Myths and Updates in Rosacea Treatment
10/07/2024
Linda Stein Gold, MD
Dispelling common misconceptions about the disease and advancing the development of more tolerable topical and oral therapies can offer hope for improved patient outcomes.
Dispelling common misconceptions about the disease and advancing the development of more tolerable topical and oral therapies can offer hope for improved patient outcomes.
Dispelling common misconceptions...
10/07/2024
The Dermatologist
NRS Approved Features
Establishing a Core Domain Set for Rosacea Clinical Trials
08/05/2024
Riya Gandhi, MA
A recent consensus statement addresses the need for standardized outcome measures in clinical trials involving patients with rosacea.
A recent consensus statement addresses the need for standardized outcome measures in clinical trials involving patients with rosacea.
A recent consensus statement...
08/05/2024
The Dermatologist
NRS Approved Features
Optimizing Skin Care in Rosacea Management
05/03/2024
Riya Gandhi, MA
For this year’s National Rosacea Awareness Month, Dr Hilary Baldwin sheds light on the crucial role of proper skin care in managing rosacea alongside medical therapies.
For this year’s National Rosacea Awareness Month, Dr Hilary Baldwin sheds light on the crucial role of proper skin care in managing rosacea alongside medical therapies.
For this year’s National Rosacea...
05/03/2024
The Dermatologist
NRS Approved Features
Rosacea Research Roundup
02/07/2024
Andrew Huff
Recent research shines light on rosacea’s complex disease process and provides avenues for further investigation.
Recent research shines light on rosacea’s complex disease process and provides avenues for further investigation.
Recent research shines light on...
02/07/2024
The Dermatologist
NRS Approved Features
The Importance of Patient-Reported Outcome Measures in Acne and Rosacea Clinical Trials
12/05/2023
Riya Gandhi, MA
Better utilization of patient-reported outcomes in clinical trials, other clinical studies, and in our clinical practice is an opportunity to gather meaningful data on patients’ lived experiences.
Better utilization of patient-reported outcomes in clinical trials, other clinical studies, and in our clinical practice is an opportunity to gather meaningful data on patients’ lived experiences.
Better utilization of...
12/05/2023
The Dermatologist
NRS Approved Features
Introducing the Seal of Acceptance Program
09/11/2023
Riya Gandhi, MA
New National Rosacea Society resource seeks to empower patients with rosacea and enhance their quality of life.
New National Rosacea Society resource seeks to empower patients with rosacea and enhance their quality of life.
New National Rosacea Society...
09/11/2023
The Dermatologist
NRS Approved Features
Optimizing Rosacea Care
05/08/2023
Jessica Garlewicz
To achieve optimal results, physicians and patients should work together to identify appropriate therapies and monitor their progress.
To achieve optimal results, physicians and patients should work together to identify appropriate therapies and monitor their progress.
To achieve optimal results,...
05/08/2023
The Dermatologist

Quizzes

acne
Quiz
Quiz: Pathophysiologic Pillars of Acne
09/25/2025
Jessica Garlewicz
Which of the following is not 1 of the 4 core pathophysiologic pillars of acne?
Which of the following is not 1 of the 4 core pathophysiologic pillars of acne?
Which of the following is not 1...
09/25/2025
The Dermatologist
psoriasis
Quiz
Quiz: Risk of Developing Psoriatic Arthritis in Patients with Psoriasis
09/25/2025
Jessica Garlewicz
Which of the following clinical features is most strongly associated with an increased risk of developing psoriatic arthritis in patients with psoriasis?
Which of the following clinical features is most strongly associated with an increased risk of developing psoriatic arthritis in patients with psoriasis?
Which of the following clinical...
09/25/2025
The Dermatologist
Quiz
When Should You Start a JAK Inhibitor for AA?
09/22/2025
Riya Gandhi, MA
Clinicians vary in when they escalate to JAK inhibitor therapy for alopecia areata. Take the quiz to see if your threshold aligns with current expert consensus.
Clinicians vary in when they escalate to JAK inhibitor therapy for alopecia areata. Take the quiz to see if your threshold aligns with current expert consensus.
Clinicians vary in when they...
09/22/2025
The Dermatologist
Quiz
Which Systemic Therapy Raises Red Flags in Older Adults?
09/18/2025
Riya Gandhi, MA
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Older patients need special consideration. Take the quiz to identify which systemic drug class carries higher risks—like thrombosis and malignancy—and requires extra caution in aging populations.
Older patients need special...
09/18/2025
The Dermatologist
Quiz
How Long Before You Call a JAK Inhibitor Non-Responsive?
09/15/2025
Riya Gandhi, MA
What’s the minimum trial duration before judging JAK efficacy in AA? Test your clinical timing.
What’s the minimum trial duration before judging JAK efficacy in AA? Test your clinical timing.
What’s the minimum trial...
09/15/2025
The Dermatologist
Quiz
What’s the Go-To Adjunct With JAKs in AA Regrowth?
09/08/2025
Riya Gandhi, MA
JAK inhibitors are central, but what’s commonly used alongside them in practice to boost hair regrowth? Take the quiz to find out.
JAK inhibitors are central, but what’s commonly used alongside them in practice to boost hair regrowth? Take the quiz to find out.
JAK inhibitors are central, but...
09/08/2025
The Dermatologist
psoriasis
Quiz
NPF Quiz: The Primary Goal of the S.T.R.A.N.D. Network
09/04/2025
Jessica Garlewicz
What is one of the primary goals of the S.T.R.A.N.D. Network as described by Dr Chesahna Kindred?
What is one of the primary goals of the S.T.R.A.N.D. Network as described by Dr Chesahna Kindred?
What is one of the primary goals...
09/04/2025
The Dermatologist
Quiz
Ethical Arguments in AA: Cosmetic vs. Medical
08/21/2025
Explore the ethical flaws in labeling alopecia areata as a cosmetic concern. Take the quiz to uncover the strongest rationale for reclassifying AA as a medical condition.
Explore the ethical flaws in labeling alopecia areata as a cosmetic concern. Take the quiz to uncover the strongest rationale for reclassifying AA as a medical condition.
Explore the ethical flaws in...
08/21/2025
The Dermatologist
psoriasis
Quiz
True or False: TYK2 Inhibition
08/14/2025
Jessica Garlewicz
True or False: TYK2 inhibition blocks IL-12 and IL-23 signaling, both of which contribute to the activation of Th17 cells in psoriasis.
True or False: TYK2 inhibition blocks IL-12 and IL-23 signaling, both of which contribute to the activation of Th17 cells in psoriasis.
True or False: TYK2 inhibition...
08/14/2025
The Dermatologist
alopecia areata
Quiz
Alopecia Areata—JAK Inhibitor Indications
08/14/2025
Jessica Garlewicz
What is the main reason patients on JAK inhibitors for alopecia areata require regular monitoring?
What is the main reason patients on JAK inhibitors for alopecia areata require regular monitoring?
What is the main reason patients...
08/14/2025
The Dermatologist

News

rosacea
News
Consensus on a Core Outcome Set for Rosacea in Clinical Trials and Practice
10/31/2024
Riya Gandhi, MA
A standardized set of outcomes could facilitate more effective data comparison across studies, improving research and clinical care for rosacea.
A standardized set of outcomes could facilitate more effective data comparison across studies, improving research and clinical care for rosacea.
A standardized set of outcomes...
10/31/2024
The Dermatologist
News
Lower Quality of Life Reported Among Patients With Acne, Rosacea, and Seborrheic Dermatitis
04/10/2023
Lisa Kuhns, PhD, MD
The quality of life among patients with acne, rosacea, and seborrheic dermatitis is significantly lower when compared with healthy people, and these patients experience more negative feelings about themselves as a result of their skin...
The quality of life among patients with acne, rosacea, and seborrheic dermatitis is significantly lower when compared with healthy people, and these patients experience more negative feelings about themselves as a result of their skin...
The quality of life among...
04/10/2023
The Dermatologist
News
Trait Emotional Intelligence Protective Against Distressing States in Rosacea
04/05/2023
Lisa Kuhns, PhD, MD
Self-esteem and social phobia mediate the relationship between trait emotional intelligence (EI) and general distress, and high levels of trait El may protect against the onset of distressing states in rosacea, according to a study published...
Self-esteem and social phobia mediate the relationship between trait emotional intelligence (EI) and general distress, and high levels of trait El may protect against the onset of distressing states in rosacea, according to a study published...
Self-esteem and social phobia...
04/05/2023
The Dermatologist
News
Rosacea in Patients With Diabetes Increases the Risk of Eye Diseases
12/06/2022
Riya Gandhi, MA
According to a study published in The Asia-Pacific Journal of Ophthalmology, patients with diabetes and rosacea are at an increased risk for diabetic macular edema, dry eye disease, glaucoma, and cataract.
According to a study published in The Asia-Pacific Journal of Ophthalmology, patients with diabetes and rosacea are at an increased risk for diabetic macular edema, dry eye disease, glaucoma, and cataract.
According to a study published...
12/06/2022
The Dermatologist
News
Consensus Recommendations on Holistic Skin Care Routines for Dermatologic Conditions
12/06/2022
Jessica Garlewicz
Consensus recommendations on providing practical guidance on the role of cleansing, moisturizing, and photoprotection (CMP) in holistic care to reach a better patient compliance, satisfaction, and treatment outcome are outlined in a recent...
Consensus recommendations on providing practical guidance on the role of cleansing, moisturizing, and photoprotection (CMP) in holistic care to reach a better patient compliance, satisfaction, and treatment outcome are outlined in a recent...
Consensus recommendations on...
12/06/2022
The Dermatologist
News
Ivermectin Is an Efficient Treatment for Rosacea
10/19/2022
Riya Gandhi, MA
Researchers aimed to investigate ivermectin treatment in rosacea and how novel smartphone technology can support monitoring rosacea-associated signs and symptoms in an open monocentric pilot study.
Researchers aimed to investigate ivermectin treatment in rosacea and how novel smartphone technology can support monitoring rosacea-associated signs and symptoms in an open monocentric pilot study.
Researchers aimed to investigate...
10/19/2022
The Dermatologist
News
Patients With Blepharitis Should Be Examined for Facial Dermatoses
10/19/2022
Jessica Garlewicz
According to a recent study published in Dermatology Practical & Conceptual, facial dermatoses frequently occur in patients with blepharitis. These patients should be examined in dermatology clinics for early detection, which will improve...
According to a recent study published in Dermatology Practical & Conceptual, facial dermatoses frequently occur in patients with blepharitis. These patients should be examined in dermatology clinics for early detection, which will improve...
According to a recent study...
10/19/2022
The Dermatologist
News
Long-Pulsed Alexandrite Plus Low-Fluence Nd:YAG Laser to Treat Rosacea
10/19/2022
Riya Gandhi, MA
According to a study published in Lasers in Surgery and Medicine, long-pulsed alexandrite laser (LPAL) may be an alternative treatment option for rosacea, producing results comparable to pulsed-dye laser (PDL) in reducing the erythema index...
According to a study published in Lasers in Surgery and Medicine, long-pulsed alexandrite laser (LPAL) may be an alternative treatment option for rosacea, producing results comparable to pulsed-dye laser (PDL) in reducing the erythema index...
According to a study published...
10/19/2022
The Dermatologist
News
BDNF Serum Level is a Potential Biomarker for Depression in Patients With Rosacea
07/08/2022
Riya Gandhi, MA
Researchers aimed to demonstrate the potential association between BDNF and depression in patients with rosacea.
Researchers aimed to demonstrate the potential association between BDNF and depression in patients with rosacea.
Researchers aimed to demonstrate...
07/08/2022
The Dermatologist
News
Ocular Compromise Among Patients With Rosacea
03/08/2022
Jessica Garlewicz
Researchers performed a descriptive, observational, retrospective, and cross-sectional study to report the prevalence, clinical signs, and therapeutic modalities for ocular rosacea.
Researchers performed a descriptive, observational, retrospective, and cross-sectional study to report the prevalence, clinical signs, and therapeutic modalities for ocular rosacea.
Researchers performed a...
03/08/2022
The Dermatologist
AD
FDA Alerts
FDA Approves Opzelura for Atopic Dermatitis in Children Aged 2–11
09/18/2025
Riya Gandhi, MA
US FDA approved Opzelura (ruxolitinib) cream 1.5% for the short-term and noncontinuous chronic treatment of mild-to-moderate AD in nonimmunocompromised children aged 2 years and older.
US FDA approved Opzelura (ruxolitinib) cream 1.5% for the short-term and noncontinuous chronic treatment of mild-to-moderate AD in nonimmunocompromised children aged 2 years and older.
US FDA approved Opzelura...
09/18/2025
The Dermatologist
FDA Alerts
Anzupgo Available for Prescribing Today
09/08/2025
Coleen Stern, MA
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved...
09/08/2025
The Dermatologist
psoriatic arthritis
News
Rare Case Highlights Diagnostic and Treatment Challenges in PsA–Myopathy Overlap
09/02/2025
Jessica Garlewicz
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a...
09/02/2025
The Dermatologist
psoriatic arthritis
News
Real-World Data Support ITABIO Guidelines for Second-Line Biologic Use in Inflammatory Arthritis
09/02/2025
Jessica Garlewicz
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment...
09/02/2025
The Dermatologist
psoriasis
News
Study Links Hypothyroidism to Psoriasis, Independent of Disease Severity
09/02/2025
Jessica Garlewicz
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that...
09/02/2025
The Dermatologist
psoriasis
News
Beta-Blockers Not Linked to Increased Psoriasis Risk, Study Finds
09/02/2025
Jessica Garlewicz
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis...
09/02/2025
The Dermatologist
psoriasis
News
Study Finds Distinct Psychosocial Burdens in Early- vs Late-Onset Psoriasis
08/14/2025
Jessica Garlewicz
A new cross-sectional study comparing early-onset and late-onset psoriasis highlights key clinical and psychosocial differences that may inform individualized care strategies for dermatologists.
A new cross-sectional study comparing early-onset and late-onset psoriasis highlights key clinical and psychosocial differences that may inform individualized care strategies for dermatologists.
A new cross-sectional study...
08/14/2025
The Dermatologist
psoriasis
News
Study Highlights Emerging Role of Stem Cells in Psoriasis Pathogenesis
08/14/2025
Jessica Garlewicz
Psoriasis is traditionally understood as a T cell–mediated disease, driven largely by Th1 and Th17 cell activation and impaired regulatory T cell (T-reg) function.
Psoriasis is traditionally understood as a T cell–mediated disease, driven largely by Th1 and Th17 cell activation and impaired regulatory T cell (T-reg) function.
Psoriasis is traditionally...
08/14/2025
The Dermatologist
psoriasis
News
Comorbidity Patterns in Moderate-to-Severe Psoriasis Highlight Need for Integrated Clinical Management
07/22/2025
Jessica Garlewicz
By incorporating comorbidity surveillance into dermatologic care, clinicians can improve disease control, minimize therapeutic risks, and enhance overall patient quality of life.
By incorporating comorbidity surveillance into dermatologic care, clinicians can improve disease control, minimize therapeutic risks, and enhance overall patient quality of life.
By incorporating comorbidity...
07/22/2025
The Dermatologist
psoriatic arthritis
News
TNF Inhibitors Improve Clinical Outcomes in csDMARD-Inadequate Psoriatic Arthritis, Review Finds
07/22/2025
Jessica Garlewicz
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists,...
07/22/2025
The Dermatologist
New Issue - September 2025

Current Issue

September 2025
Volume 33
Issue 6
Current Issue
Issue Archive
The Dermatologist Newsletter

Recent News

rosacea
News
Consensus on a Core Outcome Set for Rosacea in Clinical Trials and Practice
10/31/2024
Riya Gandhi, MA
A standardized set of outcomes could facilitate more effective data comparison across studies, improving research and clinical care for rosacea.
A standardized set of outcomes could facilitate more effective data comparison across studies, improving research and clinical care for rosacea.
A standardized set of outcomes...
10/31/2024
The Dermatologist
News
Lower Quality of Life Reported Among Patients With Acne, Rosacea, and Seborrheic Dermatitis
04/10/2023
Lisa Kuhns, PhD, MD
The quality of life among patients with acne, rosacea, and seborrheic dermatitis is significantly lower when compared with healthy people, and these patients experience more negative feelings about themselves as a result of their skin...
The quality of life among patients with acne, rosacea, and seborrheic dermatitis is significantly lower when compared with healthy people, and these patients experience more negative feelings about themselves as a result of their skin...
The quality of life among...
04/10/2023
The Dermatologist
News
Trait Emotional Intelligence Protective Against Distressing States in Rosacea
04/05/2023
Lisa Kuhns, PhD, MD
Self-esteem and social phobia mediate the relationship between trait emotional intelligence (EI) and general distress, and high levels of trait El may protect against the onset of distressing states in rosacea, according to a study published...
Self-esteem and social phobia mediate the relationship between trait emotional intelligence (EI) and general distress, and high levels of trait El may protect against the onset of distressing states in rosacea, according to a study published...
Self-esteem and social phobia...
04/05/2023
The Dermatologist
News
Rosacea in Patients With Diabetes Increases the Risk of Eye Diseases
12/06/2022
Riya Gandhi, MA
According to a study published in The Asia-Pacific Journal of Ophthalmology, patients with diabetes and rosacea are at an increased risk for diabetic macular edema, dry eye disease, glaucoma, and cataract.
According to a study published in The Asia-Pacific Journal of Ophthalmology, patients with diabetes and rosacea are at an increased risk for diabetic macular edema, dry eye disease, glaucoma, and cataract.
According to a study published...
12/06/2022
The Dermatologist
News
Consensus Recommendations on Holistic Skin Care Routines for Dermatologic Conditions
12/06/2022
Jessica Garlewicz
Consensus recommendations on providing practical guidance on the role of cleansing, moisturizing, and photoprotection (CMP) in holistic care to reach a better patient compliance, satisfaction, and treatment outcome are outlined in a recent...
Consensus recommendations on providing practical guidance on the role of cleansing, moisturizing, and photoprotection (CMP) in holistic care to reach a better patient compliance, satisfaction, and treatment outcome are outlined in a recent...
Consensus recommendations on...
12/06/2022
The Dermatologist
News
Ivermectin Is an Efficient Treatment for Rosacea
10/19/2022
Riya Gandhi, MA
Researchers aimed to investigate ivermectin treatment in rosacea and how novel smartphone technology can support monitoring rosacea-associated signs and symptoms in an open monocentric pilot study.
Researchers aimed to investigate ivermectin treatment in rosacea and how novel smartphone technology can support monitoring rosacea-associated signs and symptoms in an open monocentric pilot study.
Researchers aimed to investigate...
10/19/2022
The Dermatologist
News
Patients With Blepharitis Should Be Examined for Facial Dermatoses
10/19/2022
Jessica Garlewicz
According to a recent study published in Dermatology Practical & Conceptual, facial dermatoses frequently occur in patients with blepharitis. These patients should be examined in dermatology clinics for early detection, which will improve...
According to a recent study published in Dermatology Practical & Conceptual, facial dermatoses frequently occur in patients with blepharitis. These patients should be examined in dermatology clinics for early detection, which will improve...
According to a recent study...
10/19/2022
The Dermatologist
News
Long-Pulsed Alexandrite Plus Low-Fluence Nd:YAG Laser to Treat Rosacea
10/19/2022
Riya Gandhi, MA
According to a study published in Lasers in Surgery and Medicine, long-pulsed alexandrite laser (LPAL) may be an alternative treatment option for rosacea, producing results comparable to pulsed-dye laser (PDL) in reducing the erythema index...
According to a study published in Lasers in Surgery and Medicine, long-pulsed alexandrite laser (LPAL) may be an alternative treatment option for rosacea, producing results comparable to pulsed-dye laser (PDL) in reducing the erythema index...
According to a study published...
10/19/2022
The Dermatologist
News
BDNF Serum Level is a Potential Biomarker for Depression in Patients With Rosacea
07/08/2022
Riya Gandhi, MA
Researchers aimed to demonstrate the potential association between BDNF and depression in patients with rosacea.
Researchers aimed to demonstrate the potential association between BDNF and depression in patients with rosacea.
Researchers aimed to demonstrate...
07/08/2022
The Dermatologist
News
Ocular Compromise Among Patients With Rosacea
03/08/2022
Jessica Garlewicz
Researchers performed a descriptive, observational, retrospective, and cross-sectional study to report the prevalence, clinical signs, and therapeutic modalities for ocular rosacea.
Researchers performed a descriptive, observational, retrospective, and cross-sectional study to report the prevalence, clinical signs, and therapeutic modalities for ocular rosacea.
Researchers performed a...
03/08/2022
The Dermatologist
AD
FDA Alerts
FDA Approves Opzelura for Atopic Dermatitis in Children Aged 2–11
09/18/2025
Riya Gandhi, MA
US FDA approved Opzelura (ruxolitinib) cream 1.5% for the short-term and noncontinuous chronic treatment of mild-to-moderate AD in nonimmunocompromised children aged 2 years and older.
US FDA approved Opzelura (ruxolitinib) cream 1.5% for the short-term and noncontinuous chronic treatment of mild-to-moderate AD in nonimmunocompromised children aged 2 years and older.
US FDA approved Opzelura...
09/18/2025
The Dermatologist
FDA Alerts
Anzupgo Available for Prescribing Today
09/08/2025
Coleen Stern, MA
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved delgocitinib cream as the first and only treatment indicated for moderate-to-severe chronic hand eczema in adults.
FDA recently approved...
09/08/2025
The Dermatologist
psoriatic arthritis
News
Rare Case Highlights Diagnostic and Treatment Challenges in PsA–Myopathy Overlap
09/02/2025
Jessica Garlewicz
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a review of 17 similar reports, details shared immunopathogenesis and conflicting treatment responses in this rare overlap syndrome.
The case study, accompanied by a...
09/02/2025
The Dermatologist
psoriatic arthritis
News
Real-World Data Support ITABIO Guidelines for Second-Line Biologic Use in Inflammatory Arthritis
09/02/2025
Jessica Garlewicz
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment patterns and patient characteristics to assess the impact of these guidelines in real-world care.
The study evaluated treatment...
09/02/2025
The Dermatologist
psoriasis
News
Study Links Hypothyroidism to Psoriasis, Independent of Disease Severity
09/02/2025
Jessica Garlewicz
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that thyroid abnormalities may represent an independent comorbidity, rather than a direct consequence of psoriasis severity.
The findings suggest that...
09/02/2025
The Dermatologist
psoriasis
News
Beta-Blockers Not Linked to Increased Psoriasis Risk, Study Finds
09/02/2025
Jessica Garlewicz
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis challenges long-standing concerns regarding beta-blockers and their role in triggering or worsening psoriasis.
A new multi-method analysis...
09/02/2025
The Dermatologist
psoriasis
News
Study Finds Distinct Psychosocial Burdens in Early- vs Late-Onset Psoriasis
08/14/2025
Jessica Garlewicz
A new cross-sectional study comparing early-onset and late-onset psoriasis highlights key clinical and psychosocial differences that may inform individualized care strategies for dermatologists.
A new cross-sectional study comparing early-onset and late-onset psoriasis highlights key clinical and psychosocial differences that may inform individualized care strategies for dermatologists.
A new cross-sectional study...
08/14/2025
The Dermatologist
psoriasis
News
Study Highlights Emerging Role of Stem Cells in Psoriasis Pathogenesis
08/14/2025
Jessica Garlewicz
Psoriasis is traditionally understood as a T cell–mediated disease, driven largely by Th1 and Th17 cell activation and impaired regulatory T cell (T-reg) function.
Psoriasis is traditionally understood as a T cell–mediated disease, driven largely by Th1 and Th17 cell activation and impaired regulatory T cell (T-reg) function.
Psoriasis is traditionally...
08/14/2025
The Dermatologist
psoriasis
News
Comorbidity Patterns in Moderate-to-Severe Psoriasis Highlight Need for Integrated Clinical Management
07/22/2025
Jessica Garlewicz
By incorporating comorbidity surveillance into dermatologic care, clinicians can improve disease control, minimize therapeutic risks, and enhance overall patient quality of life.
By incorporating comorbidity surveillance into dermatologic care, clinicians can improve disease control, minimize therapeutic risks, and enhance overall patient quality of life.
By incorporating comorbidity...
07/22/2025
The Dermatologist
psoriatic arthritis
News
TNF Inhibitors Improve Clinical Outcomes in csDMARD-Inadequate Psoriatic Arthritis, Review Finds
07/22/2025
Jessica Garlewicz
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists, these findings reinforce current guidelines that position TNF inhibitors as a first-line biologic option for patients with active psoriatic arthritis.
For practicing dermatologists,...
07/22/2025
The Dermatologist

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use